92 related articles for article (PubMed ID: 9081306)
21. A new rapid and simple colorimetric method to detect pyrazinamide resistance in Mycobacterium tuberculosis using nicotinamide.
Martin A; Takiff H; Vandamme P; Swings J; Palomino JC; Portaels F
J Antimicrob Chemother; 2006 Aug; 58(2):327-31. PubMed ID: 16751203
[TBL] [Abstract][Full Text] [Related]
22. Comparative evaluation of Löwenstein-Jensen proportion method, BacT/ALERT 3D system, and enzymatic pyrazinamidase assay for pyrazinamide susceptibility testing of Mycobacterium tuberculosis.
Singh P; Wesley C; Jadaun GP; Malonia SK; Das R; Upadhyay P; Faujdar J; Sharma P; Gupta P; Mishra AK; Singh K; Chauhan DS; Sharma VD; Gupta UD; Venkatesan K; Katoch VM
J Clin Microbiol; 2007 Jan; 45(1):76-80. PubMed ID: 17093022
[TBL] [Abstract][Full Text] [Related]
23. Determination of the susceptibility of Mycobacterium tuberculosis to pyrazinamide in liquid and solid media assessed by a colorimetric nitrate reductase assay.
Syre H; Øvreås K; Grewal HM
J Antimicrob Chemother; 2010 Apr; 65(4):704-12. PubMed ID: 20118493
[TBL] [Abstract][Full Text] [Related]
24. Esters of Pyrazinoic Acid Are Active against Pyrazinamide-Resistant Strains of Mycobacterium tuberculosis and Other Naturally Resistant Mycobacteria In Vitro and Ex Vivo within Macrophages.
Pires D; Valente E; Simões MF; Carmo N; Testa B; Constantino L; Anes E
Antimicrob Agents Chemother; 2015 Dec; 59(12):7693-9. PubMed ID: 26438493
[TBL] [Abstract][Full Text] [Related]
25. Susceptibility of Mycobacterium tuberculosis to pyrazinamide and its relationship to pyrazinamidase activity.
Butler WR; Kilburn JO
Antimicrob Agents Chemother; 1983 Oct; 24(4):600-1. PubMed ID: 6418066
[TBL] [Abstract][Full Text] [Related]
26. Growth inhibition of Mycobacterium tuberculosis by polyoxyethylene stearate present in the BACTEC pyrazinamide susceptibility test.
Miller MA; Thibert L; Desjardins F; Siddiqi SH; Dascal A
J Clin Microbiol; 1996 Jan; 34(1):84-6. PubMed ID: 8748279
[TBL] [Abstract][Full Text] [Related]
27. Susceptibility testing of Mycobacterium tuberculosis to pyrazinamide.
Salfinger M; Kafader FM
Zentralbl Bakteriol Mikrobiol Hyg A; 1987 Jul; 265(3-4):404-7. PubMed ID: 3118600
[TBL] [Abstract][Full Text] [Related]
28. Pyrazinamide is not active in vitro against Mycobacterium avium complex.
Heifets LB; Iseman MD; Crowle AJ; Lindholm-Levy PJ
Am Rev Respir Dis; 1986 Dec; 134(6):1287-8. PubMed ID: 3789528
[TBL] [Abstract][Full Text] [Related]
29. Simple fibroblast-based assay to test the pyrazinamide susceptibility of Mycobacterium tuberculosis.
Takii T; Hamasaki S; Hirano K; Abe C; Onozaki K
Antimicrob Agents Chemother; 2005 Feb; 49(2):804-7. PubMed ID: 15673774
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of a radiometric method for pyrazinamide susceptibility testing of Mycobacterium tuberculosis.
Tarrand JJ; Spicer AD; Gröschel DH
Antimicrob Agents Chemother; 1986 Dec; 30(6):852-5. PubMed ID: 3101586
[TBL] [Abstract][Full Text] [Related]
31. Characterization of pncA mutations in pyrazinamide-resistant Mycobacterium tuberculosis in Brazil.
Rodrigues Vde F; Telles MA; Ribeiro MO; Cafrune PI; Rossetti ML; Zaha A
Antimicrob Agents Chemother; 2005 Jan; 49(1):444-6. PubMed ID: 15616332
[TBL] [Abstract][Full Text] [Related]
32. Pyrazinamide resistance in multidrug-resistant Mycobacterium tuberculosis isolates in Japan.
Ando H; Mitarai S; Kondo Y; Suetake T; Sekiguchi JI; Kato S; Mori T; Kirikae T
Clin Microbiol Infect; 2010 Aug; 16(8):1164-8. PubMed ID: 19832709
[TBL] [Abstract][Full Text] [Related]
33. Pyrazinamide resistance and mutations in pncA among isolates of Mycobacterium tuberculosis from Khyber Pakhtunkhwa, Pakistan.
Khan MT; Malik SI; Ali S; Masood N; Nadeem T; Khan AS; Afzal MT
BMC Infect Dis; 2019 Feb; 19(1):116. PubMed ID: 30728001
[TBL] [Abstract][Full Text] [Related]
34. Mutations found in the pncA gene of Mycobacterium tuberculosis in clinical pyrazinamide-resistant isolates from a local region of China.
Zhang H; Bi LJ; Li CY; Sun ZG; Deng JY; Zhang XE
J Int Med Res; 2009; 37(5):1430-5. PubMed ID: 19930847
[TBL] [Abstract][Full Text] [Related]
35. Characterization of pncA mutations of pyrazinamide-resistant Mycobacterium tuberculosis in Turkey.
Yüksel P; Tansel O
New Microbiol; 2009 Apr; 32(2):153-8. PubMed ID: 19579692
[TBL] [Abstract][Full Text] [Related]
36. Pyrazinamide resistance associated with pncA gene mutation in Mycobacterium tuberculosis in Japan.
Endoh T; Yagihashi A; Uehara N; Kobayashi D; Tsuji N; Nakamura M; Hayashi S; Fujii N; Watanabe N
Epidemiol Infect; 2002 Apr; 128(2):337-42. PubMed ID: 12002553
[TBL] [Abstract][Full Text] [Related]
37. [Determining drug resistance of the clinical strains of Mycobacterium tuberculosis to pyrazinamide].
Nizova AV; Stepanshina VN; Maĭskaia NV; Mironova RI; Bogun AG; Domotenko LV; Morozova TP; Shemiakin IG
Mol Gen Mikrobiol Virusol; 2008; (4):23-6. PubMed ID: 19172875
[TBL] [Abstract][Full Text] [Related]
38. Rapid, automated, nonradiometric susceptibility testing of Mycobacterium tuberculosis complex to four first-line antituberculous drugs used in standard short-course chemotherapy.
Johansen IS; Thomsen VØ; Marjamäki M; Sosnovskaja A; Lundgren B
Diagn Microbiol Infect Dis; 2004 Oct; 50(2):103-7. PubMed ID: 15474318
[TBL] [Abstract][Full Text] [Related]
39. [Pyrazinamide monoresistant Mycobacterium tuberculosis in Manisa region, Turkey].
Ozkütük N; Ecemiş T; Sürücüoğlu S
Mikrobiyol Bul; 2008 Oct; 42(4):585-90. PubMed ID: 19149079
[TBL] [Abstract][Full Text] [Related]
40. [Investigation of pyrazinamide resistance in multidrug-resistant tuberculosis cases in Hospital of Pulmonary Diseases, Izmir, Turkey].
Senol G; Coşkun M; Gündüz AT; Biçmen C; Gayaf M; Ozsöz A
Mikrobiyol Bul; 2008 Oct; 42(4):591-7. PubMed ID: 19149080
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
